RoC Skincare has completed a pilot clinical study that tested its patented clinical retinol on identical twin women, pairing biometric readings from Oura Rings with conventional clinical skin measurements. The brand is now recruiting 30 pairs of identical twins aged 40 and older who live in the US for a 12-week phase, with results expected by mid-2027.
Art Pellegrino, RoC's chief scientific officer, said the pilot was meant to establish whether the twin model could work at all rather than to quantify how much visible aging comes from genes and how much from daily life. He said the team's conclusion was that it could, and that the expanded study is intended to answer the genetic-versus-lifestyle question the pilot left open.
Why identical twins
Because identical twins share DNA and much of their early environment, differences in the way their skin ages are harder to attribute to genetics, Pellegrino said, which makes lifestyle and environmental exposure the more likely explanation. In his description, identical twins work as close to a natural control group as dermatological research is likely to find, allowing a product's contribution to be isolated more precisely than in a conventional trial population.
What the pilot showed
According to Pellegrino, twins assigned to the placebo arm finished the pilot with signs of aging that were similar to or worse than at the start, while twins in the treatment arm recorded improvements of 20% or more within four weeks. Those figures describe the pilot as characterized by the brand and have not been independently reported.
Wearables as a record of daily life
Participants wear an Oura Ring, a consumer wearable that logs sleep, stress indicators, heart rate, heart rate variability and temperature trends, so researchers can compare each twin's daily conditions alongside her clinical skin readings. RoC cannot guarantee that twins share sun exposure or diet, so it is recruiting pairs with comparable levels of existing environmental damage and tracking sleep and stress closely throughout the study.
Pellegrino said wearables are opening a way for the industry to factor how people actually live into skincare recommendations. In practice, the design would let researchers check whether stretches of poor sleep line up with lower hydration readings, or whether the twin under less stress sees fine lines improve sooner.
Scope and limits
The pilot did not attempt to apportion skin aging between genetics and lifestyle; that is the remit of the expanded 12-week study, which RoC frames as one stage in a longer research program on what it calls skin span — how long skin keeps looking its best. The company also wants to know whether participants who see visible improvement report feeling less stressed, a question that runs in the opposite direction to its stress-tracking premise.
Skin changes are assessed through expert grading, digital photography, corneometer readings and participant self-assessment. Pellegrino said the findings will shape how RoC develops products for skin longevity and how it designs its clinical studies going forward.